Le Lézard
Classified in: Health
Subjects: SVY, CFG

Statement from the CPHO - The time is now - joining forces to eliminate tuberculosis in Canada


OTTAWA, March 22, 2018 /CNW/ - As we approach World Tuberculosis Day on Saturday, March 24, I am pleased to release my first public health spotlight report to shine a light on one of my key priorities: to accelerate our efforts toward elimination of tuberculosis (TB) in Canada.

TB is a preventable and curable disease, yet it remains one of the most common infectious diseases worldwide. Although rates of TB in Canada are among the lowest in the world, TB remains an important public health issue here at home for Indigenous peoples, in particular Inuit, and individuals born in countries with a high incidence of TB.

TB thrives on inequity and is aided and abetted by social determinants of health such as poverty, food insecurity and inadequate housing. It is these disparities and the stigma that accompanies them that need our attention so all Canadians can access and achieve their optimal health without physical, social and psychological barriers.

There is no better time than now to accelerate our efforts to eliminate TB. Improved rapid diagnostics for active TB disease are now available, allowing for timely treatment and reduced transmission. Reactivation of ?latent TB infection (LTBI) remains a major source of new active TB disease and transmission. Better tests and approaches to identify those individuals at the highest risk for disease reactivation, combined with more timely and effective LTBI treatment plans, all offer great promise.

The key to achieving TB elimination in Canada lies in collaborative action. Ultimately, the solutions to this complex social disease will be driven by the communities themselves, with sustained support from many players, including governments, academics, experts and other partners. Efforts that address social inequities coupled with improved diagnosis and treatment of active TB disease and LTBI will level the playing field and help eliminate TB in all of Canada.

Visit Canada.ca to read my full report where you can find out more about TB in Canada and the collective actions needed eliminate the disease, remove health disparities for sustained success and improve overall health.

Dr. Theresa Tam
Chief Public Health Officer of Canada

 

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 07:45
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...



News published on and distributed by: